Compare RAY & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAY | HKPD |
|---|---|---|
| Founded | 1993 | 2016 |
| Country | Hong Kong | Hong Kong |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 10.6M |
| IPO Year | 2024 | 2025 |
| Metric | RAY | HKPD |
|---|---|---|
| Price | $4.58 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 104.4K | 26.9K |
| Earning Date | 01-15-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | $9,391,194.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.44 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $1.40 | $0.68 |
| 52 Week High | $58.88 | $2.76 |
| Indicator | RAY | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 77.58 | 47.86 |
| Support Level | $4.36 | $0.76 |
| Resistance Level | $5.49 | $0.84 |
| Average True Range (ATR) | 0.47 | 0.06 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 74.12 | 45.44 |
Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.